FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
Akira WatanabeNorifumi HarimotoTakehiko YokoboriKenichiro ArakiNorio KuboTakamichi IgarashiMariko TsukagoshiNorihiro IshiiTakahiro YamanakaTadashi HandaTetsunari OyamaTetsuya HiguchiKen ShirabePublished in: International journal of clinical oncology (2019)
SUV reflected tumor proliferation or metabolic factors in CRLM. FDG-PET could be a useful modality for assessing tumor viability and may provide useful information regarding the appropriate treatment strategy for CRLM.